News
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi Health sell GLP-1 drugs for lower prices than what you’d pay at a pharmacy, ...
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
We recently published a list of Investors Rushed Into These 10 Stocks Today. In this article, we are going to take a look at ...
Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...
Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of ...
Hims asked expert barbers for their takes on the best haircuts for a receding hairline—styles that are flattering, easy to ...
2d
Zacks Investment Research on MSNHims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...
HIMS posted stellar Q1 FY 2025; growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Click here to ...
We recently published a list of 10 Stocks Got Wiped Out. Are You Holding Any? In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results